
FIGURE 1.
Flowchart of the study design.
CSI = craniospinal irradiation; CT = computed tomography; KBP = knowledge-based planning; VMAT = volumetric modulated arc therapy

FIGURE 2.
Example of the target and field setup. (A) The arrangement of the brain field (dotted lines), spine-superior field (solid lines), spine-inferior field (dashed lines), and their isocenters. Each field overlaps at least 5 cm for the low-dose gradient junction. (B) Full arc was used on the brain field. (C) Partial arc was used in the spinal fields for arm sparing.
TABLE 1.
Dosimetric comparison between manual plans, RapidPlan initial, and RapidPlan final
| Parameters | Goals | Results | P value | ||||
|---|---|---|---|---|---|---|---|
| MP | RPI | RPF | MP vs. RPI | MP vs. RPF | RPI vs. RPF | ||
| CTV | |||||||
| V95 [%] | > 99 | 99.99 ± 0.03 | 99.98 ± 0.03 | 99.97 ± 0.03 | 0.36 | 0.03* | 0.09 |
| V100 [%] | > 99 | 99.20 ± 0.17 | 98.37 ± 0.33 | 99.37 ± 0.23 | < 0.01** | 0.07 | < 0.01** |
| V107 [%] | Minimize | 0.62 ± 0.59 | 2.94 ± 4.33 | 0.46 ± 0.66 | < 0.01** | 0.16 | < 0.01** |
| Dmean [Gy] | 36 | 37.23 ± 0.18 | 37.31 ± 0.21 | 37.22 ± 0.24 | 0.07 | 0.87 | 0.13 |
| Dmax [Gy] | Minimize | 39.38 ± 0.40 | 40.38 ± 0.57 | 39.42 ± 0.41 | < 0.01** | 0.78 | < 0.01** |
| D2 [%] | < 107 | 106.12 ± 0.73 | 106.95 ± 0.96 | 105.72 ± 0.84 | < 0.01** | 0.19 | < 0.01** |
| PTV | |||||||
| V95 [%] | > 98 | 99.68 ± 0.15 | 99.55 ± 0.23 | 99.24 ± 0.32 | 0.03* | < 0.01** | < 0.01** |
| V100 [%] | = 95 | 95.00 ± 0.00 | 95.00 ± 0.00 | 95.00 ± 0.00 | - | - | - |
| V107 [%] | Minimize | 0.62 ± 0.57 | 3.01 ± 4.12 | 0.44 ± 0.61 | < 0.01** | 0.17 | < 0.01** |
| Dmean [Gy] | 36 | 37.10 ± 0.16 | 37.22 ± 0.18 | 37.08 ± 0.20 | 0.05 | 0.73 | 0.01* |
| Dmax [%] | < 112 | 109.99 ± 1.17 | 112.89 ± 1.78 | 110.17 ± 1.14 | < 0.01** | 0.57 | < 0.01** |
| D2 [%] | < 107 | 106.09 ± 0.73 | 107.00 ± 0.93 | 105.71 ± 0.80 | < 0.01** | 0.21 | < 0.01** |
| CI | 1 | 0.98 ± 0.01 | 1.01 ± 0.01 | 1.00 ± 0.01 | < 0.01** | < 0.01** | 0.01* |
| HI | 1 | 1.10 ± 0.01 | 1.13 ± 0.02 | 1.10 ± 0.01 | < 0.01** | 0.57 | < 0.01** |
TABLE 2.
Dosimetric goals and results for organs at risk
| OAR parameters | Goals | Results | P value | ||||
|---|---|---|---|---|---|---|---|
| MP | RPI | RPF | MP vs. RPF | MP vs. RPF | RPI vs. RPI | ||
| Brain | |||||||
| Dmax [Gy] | < 60 | 39.34 ± 0.39 | 40.24 ± 0.61 | 39.28 ± 0.37 | < 0.01** | 0.46 | < 0.01** |
| Brain stem | |||||||
| Dmax [Gy] | < 54 | 38.48 ± 0.41 | 39.03 ± 0.46 | 38.51 ± 0.28 | < 0.01** | 0.91 | < 0.01** |
| Chiasm | |||||||
| Dmean [Gy] | < 50 | 37.15 ± 0.35 | 37.10 ± 0.32 | 36.95 ± 0.32 | 0.69 | 0.07 | 0.06 |
| Dmax [Gy] | < 55 | 38.13 ± 0.40 | 38.73 ± 0.55 | 38.20 ± 0.26 | 0.01* | 0.46 | < 0.01** |
| Optic nerves | |||||||
| Dmean [Gy] | < 50 | 27.61 ± 3.40 | 22.90 ± 2.39 | 22.42 ± 2.29 | < 0.01** | < 0.01** | 0.05 |
| Dmax [Gy] | < 55 | 37.13 ± 0.69 | 36.36 ± 1.72 | 36.15 ± 1.39 | 0.13 | 0.02* | 0.13 |
| Eyes | |||||||
| Dmax [Gy] | < 50 | 25.55 ± 3.57 | 22.52 ± 3.83 | 21.60 ± 3.86 | 0.02* | 0.01* | 0.01* |
| Lens | |||||||
| Dmax [Gy] | < 10 | 8.40 ± 0.68 | 8.87 ± 1.00 | 8.10 ± 0.55 | 0.11 | 0.21 | < 0.01** |
| Parotid glands | |||||||
| Dmean [Gy] | < 25 | 7.38 ± 2.52 | 5.16 ± 0.39 | 4.95 ± 0.39 | < 0.01** | < 0.01** | < 0.01** |
| Spinal cord | |||||||
| Dmax [Gy] | < 50 | 38.93 ± 0.51 | 39.81 ± 0.67 | 39.04 ± 0.56 | < 0.01** | < 0.01** | < 0.01** |
| Thyroid | |||||||
| Dmax [Gy] | < 45 | 17.23 ± 4.04 | 16.68 ± 2.13 | 16.38 ± 2.04 | 0.59 | 0.36 | 0.07 |
| Lungs | |||||||
| Dmean [Gy] | < 13 | 4.63 ± 0.30 | 4.95 ± 0.43 | 4.63 ± 0.24 | 0.03* | 0.73 | < 0.01** |
| V20Gy [%] | < 22 | 0.06 ± 0.11 | 0.04 ± 0.08 | 0.03 ± 0.04 | 0.64 | 0.44 | 0.33 |
| V5Gy [%] | < 42 | 36.48 ± 2.88 | 42.77 ± 5.62 | 37.11 ± 2.87 | 0.01* | 0.69 | < 0.01** |
| Heart | |||||||
| Dmean [Gy] | < 10 | 6.76 ± 1.47 | 5.53 ± 0.82 | 5.70 ± 0.93 | 0.01* | 0.02* | 0.33 |
| V40Gy [%] | < 3 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | - | - |
| V18Gy [%] | < 5 | 0.04 ± 0.10 | 0.01 ± 0.03 | 0.01 ± 0.02 | 0.31 | 0.23 | 0.41 |
| Esophagus | |||||||
| Dmean [Gy] | < 34 | 14.34 ± 1.62 | 13.23 ± 1.63 | 13.30 ± 1.74 | 0.01* | < 0.01** | 0.96 |
| Liver | |||||||
| Dmean [Gy] | < 30 | 4.82 ± 0.94 | 4.57 ± 0.73 | 4.45 ± 0.70 | 0.61 | 0.33 | < 0.01** |
| Kidneys | |||||||
| Dmean [Gy] | < 18 | 2.81 ± 1.17 | 2.47 ± 0.46 | 2.38 ± 0.43 | 0.96 | 0.73 | < 0.01** |
TABLE 3.
The mean dose of the OARs outside the targets contours
| Organ | Mean dose | P value | ||||
|---|---|---|---|---|---|---|
| MP | RPI | RPF | MP vs. RPI | MP vs. RPF | RPI vs. RPF | |
| Optic nerves | 27.61 ± 3.40 | 22.90 ± 2.39 | 22.42 ± 2.29 | < 0.01** | < 0.01** | 0.05 |
| Eyes | 12.11 ± 1.99 | 10.16 ± 0.55 | 9.83 ± 0.74 | 0.01* | 0.01* | 0.02* |
| Lens | 7.09 ± 0.67 | 7.21 ± 0.52 | 6.78 ± 0.39 | 0.43 | 0.16 | < 0.01** |
| Parotid glands | 7.38 ± 2.52 | 5.16 ± 0.39 | 4.95 ± 0.39 | < 0.01** | < 0.01** | < 0.01** |
| Thyroid | 10.41 ± 3.37 | 9.00 ± 1.94 | 8.51 ± 2.07 | 0.06 | 0.04* | < 0.01** |
| Lungs | 4.63 ± 0.30 | 4.95 ± 0.43 | 4.63 ± 0.24 | 0.03* | 0.73 | < 0.01** |
| Heart | 6.76 ± 1.47 | 5.53 ± 0.82 | 5.70 ± 0.93 | 0.01* | 0.02* | 0.33 |
| Liver | 4.82 ± 0.94 | 4.57 ± 0.73 | 4.45 ± 0.70 | 0.61 | 0.33 | < 0.01** |
| Kidneys | 2.81 ± 1.17 | 2.47 ± 0.46 | 2.38 ± 0.43 | 0.96 | 0.73 | < 0.01** |

FIGURE 3.
(A) Population-averaged dose-volume histogram (DVH) for all organs at risk and targets. (B) The population-averaged DVH for targets only.
CTV = clinical target volume; MP = manual optimization plan; PTV = planning target volumes; RPI = RapidPlan initial; RPF = final RapidPlan after manual re-optimization

FIGURE 4.
Comparison of the planning time for MP, RPI, and RPF. The error bar represents one standard deviation.
MP = manual optimization plan; RPI = RapidPlan initial; RPF = final RapidPlan after manual re-optimization